August 15, 2018 NIAID Funding News
Read this full issue online at http://www.niaid.nih.gov/
Feature Articles
NIH Gives Some Leeway to Those Conducting Prospective Basic Science Studies
NIH is implementing short-term policy flexibilities for some requirements affecting prospective basic science studies involving human participants.
Opportunities and Resources
HHS Issues Omnibus SBIR Contract Solicitation for FY 2019
Small businesses: Don't miss your chance to submit a proposal to complete research in one of many topic areas of interest to NIAID.
New FOA Focuses on Extramural Research at NIH Clinical Center
Conduct research using NIH Clinical Center resources like nursing, beds, imaging, safety oversight, and more.
New R01 and R21 Funding Opportunities To Support Universal Influenza Vaccine Research
NIAID recently released two funding opportunity announcements to support research activities that will provide foundational information to advance the development of a universal influenza vaccine.
Study Immune Response to Arthropod Blood Feeding
Consider applying for a short-term grant to better understand the immunologic events that occur during blood feeding by hematophagous arthropods such as ticks and mosquitoes.
In The News
Understand Implications of Final Rule To Delay Common Rule
Grantees may choose to implement three of the Common Rule’s provisions immediately, even though HHS is delaying implementation of the Common Rule until January 21, 2019.
Research Organizations Recognize ImmPort as a Trustworthy Source
NIAID’s ImmPort team is committed to ensuring that the public data sharing repository of immunology research and clinical trials meets community standards and best practices for open data and open science.
Resubmission Policy Redux
NIH recently issued a notice to remind researchers that the resubmission policy allows investigators to follow their unfunded resubmission (A1) with a new application (A0) and does not require the second A0 to be significantly different from the A1.
Advice Corner
Now Online: CSR AIDS and Related Research Study Sections
The AIDS and Related Research integrated review group's study sections are now publicly accessible online, and their rosters and meetings information will be online soon.
Reader Questions
- “Who sets NIAID's funding level and appropriates its dollars, and how does this work?”
- “When is the beginning of the fiscal year?”
New Funding Opportunities
- PAR-18-895, CNS-Targeted Drug Delivery Strategies for HIV (R01, Clinical Trial Not Allowed)
- RFA-HL-18-031, Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3, Clinical Trial Required)
- RFA-HL-18-033, Regenerative Medicine Innovation Projects (RMIP) (UT2, Clinical Trial Not Allowed)
- RFA-HL-18-035, Regenerative Medicine Innovation Projects (RMIP) (U44, Clinical Trial Not Allowed)
- RFA-HL-18-030, Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Studies (Collaborative U01, Clinical Trial Not Allowed)
- PA-18-393, Midcareer Investigator Award in Patient-Oriented Research (Parent K24, Independent Clinical Trial Required)
- PHS-2019-1, Solicitation of the National Institutes of Health and the Centers for Disease Control and Prevention for Small Business Innovation Research Contract Proposals
See other announcements at Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.
.png)
No hay comentarios:
Publicar un comentario